Benjamin Rome, an assistant professor of medicine at Harvard Medical School, said forthcoming research shows brand-name drug use in Medicare rose on "the order of 20-30% higher" than among privately insured adults after the 2024 cap.
f.mtr.coolA 2022 Law May Be Quietly Helping People Stay on Their MedsWith a new yearly cap on drug costs, Medicare patients are experiencing lower bills and fewer disruptions.
2 reposts4 likes